Effect of a single nucleotide polymorphism of complement decay accelerating factor (DAF) on proteinuria in BUF/Mna rat
Effect of a single nucleotide polymorphism of complement decay accelerating factor (DAF) on proteinuria in BUF/Mna rat
批准号:
14571037
负责人:
MORITA Hiroyuki
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
BUF/Mna strain spontaneously develops proteinuria due to focal and segmental glomeruloscierosis (FSGS). Fine quantitative trait locus (QTL) mapping and synteny analysis clarified that rat homologue of DAF (Daf) located on proteinuria susceptible locus, designated as Purl locus, of rat chromosome 13. A single nucleotide polymorphism in the coding sequence (cSNP) with C-T substitution was found at the nucleotide position 239 of the Daf cDNA in BUF/Mna strain. DNA was obtained in 167 [BUF/Mna x WKYINCrj] F1 x BUF/Mna rats. Urinary protein excretion of these rats were measured. However, analysis of correlation between cSNP and amount of urinary protein excretion has not been completed within the term of the present project. On the other hand, a congenic strain was established in which Purl region of BUF/Mna strain containing Daf was transferred to the genetic background of WKY/NCrj strain. Unilateral nephrectomy was performed in the congenic rats (N=7) and WKY/NCrj rats (N=7) used as controls. At 3 and 9 months, glomerulosclerosis score of the congenic rats was significantly greater than that of WKY/NCrj rats. At 3, 6, and 9 months, urinary protein excretion of the congenic rats was significantly greater than that of WKY/NCrj rats. These results confirmed that Purl region containing Daf had biologic impact on the development of FSGS.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Rossi M, Morita H, et al.(2番目): "Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney."EMBO J. 22. 236-245 (2003)
Rossi M, Morita H, et al. (2nd):“基底膜聚糖的硫酸乙酰肝素链在晶状体囊中是不可或缺的,但在肾脏中则不然。”EMBO J. 22. 236-245 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Morita H at al.: "Collagenofibrotic glomerulopathy with a widespread expression of type-V collagen."Virchows Arch. 442. 163-168 (2003)
Morita H 等人:“胶原纤维化肾小球病,广泛表达 V 型胶原。”Virchows Arch。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakao, N, Yoshimura, A., Morita, H. et al.: "(3rd): Combination treatment of angiotensin-II receptor blocker and angiotensin-converting enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomized controlled trial."LANCET. 361. 117-124 (2003)
Nakao, N、Yoshimura, A.、Morita, H. 等人:“(第 3 版):血管紧张素 II 受体阻滞剂和血管紧张素转换酶抑制剂联合治疗非糖尿病肾病 (COOPERATE):一项随机对照试验
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Suzuki, R., Morita, H.et al.: "(2nd): Mixed cryoglobulinemia due to chronic hepatitis C with severe pulmonary involvement."Internal Medicine. 42. 1210-1214 (2003)
Suzuki, R., Morita, H.et al.:“(第 2):慢性丙型肝炎引起的混合性冷球蛋白血症,伴有严重的肺部受累。”内科。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakao N, Yoshimura A, Morita H et al.: "Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE) : a randomised controlled trial."Lancet. 361. 117-124 (2003)
Nakao N、Yoshimura A、Morita H 等人:“血管紧张素 II 受体阻滞剂和血管紧张素转换酶抑制剂联合治疗非糖尿病肾病 (COOPERATE):一项随机对照试验。”《柳叶刀》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Identification of effective agent against abdominal aortic aneurysm formation
-
批准号:25670380
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:MORITA Hiroyuki
-
依托单位:
Behavior modification in patients with metabolic syndrome -an effect of EMA used with a cellular phone-
-
批准号:22500626
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2010
-
负责人:MORITA Hiroyuki
-
依托单位:
Identification of the molecule binding with the cardiac transcriptional regulator HOP and analysis on the molecular function of heart failure
-
批准号:21590925
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:MORITA Hiroyuki
-
依托单位:
Structure-based engineering of type-III polyketide synthase
-
批准号:21710235
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:MORITA Hiroyuki
-
依托单位:
Identification of a susceptible gene for the development of nephritis, which locates near the D8 GOT128 marker in rat chromosome 8
-
批准号:18500331
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2006
-
负责人:MORITA Hiroyuki
-
依托单位:
Longevity and lifestyle
-
批准号:16300220
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.8万
-
财政年份:2004
-
负责人:MORITA Hiroyuki
-
依托单位:
Phenotype analysis of perlecan mutated mice in which heparan sulfates are removed by the use of ES cell.
-
批准号:11671052
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1999
-
负责人:MORITA Hiroyuki
-
依托单位:
国内基金
海外基金
足细胞中补体系统活化以及在足细胞损伤中作用机制研究
-
批准号:81170657
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:丁洁
-
依托单位:
蛋白尿时肾小球足细胞"重塑"的作用分子及分子机制研究
-
批准号:30830105
-
项目类别:重点项目
-
资助金额:185.0万元
-
批准年份:2008
-
负责人:丁洁
-
依托单位:
从离子通道蛋白TRPC6角度探讨突变podocin致足细胞损伤的分子机制
-
批准号:30801250
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2008
-
负责人:范青锋
-
依托单位: